Jose Rafecas
Neurology · Uniontown, OHNPI 1598728149
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 181 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,118 and has fallen 99.6% since, to $13 in 2022.
Across 181 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$428
- AstraZeneca$351
- EMD Serono, Inc.$301
- Eisai Inc.$222
- Novartis$210
- Genentech, Inc.$207
- plus $2K from 32 others
Across 36 payments — averaging $19,194 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$580K
- Genentech, Inc.$58K
- Biogen$36K
- EMD Serono, Inc.$9K
- UCB SA$8K
What the payments were for
- Speaking & faculty fees$321%
- Food & beverage$3,22299%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 12 | $428 |
| AstraZeneca | 14 | $351 |
| EMD Serono, Inc. | 13 | $301 |
| Eisai Inc. | 7 | $222 |
| Novartis | 19 | $210 |
| Genentech, Inc. | 2 | $207 |
| Biogen | 24 | $184 |
| UCB, Inc. | 7 | $152 |
| Amgen(2 entities) | 9 | $138 |
| Jazz Pharmaceuticals Inc. | 7 | $133 |
| Grifols USA, LLC | 5 | $97 |
| Lundbeck LLC | 6 | $88 |
| Neurocrine Biosciences, Inc. | 7 | $85 |
| Sunovion Pharmaceuticals Inc. | 6 | $71 |
| Genentech USA, Inc. | 8 | $66 |
| Livanova USA, Inc. | 3 | $55 |
| Kyowa Kirin, Inc. | 2 | $39 |
| Supernus Pharmaceuticals, Inc. | 3 | $36 |
| Acorda Therapeutics, Inc | 2 | $32 |
| Merz North America, Inc. | 2 | $32 |
| Tanabe Pharma America, Inc. | 2 | $31 |
| GE HealthCare | 3 | $29 |
| Avanir Pharmaceuticals, Inc. | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Ironshore Pharmaceuticals Inc. | 1 | $22 |
| Adamas Pharmaceuticals, Inc. | 1 | $22 |
| CSL Behring | 1 | $20 |
| Saol Therapeutics Inc. | 1 | $20 |
| Aquestive Therapeutics, Inc. | 1 | $19 |
| MDD US Operations, LLC | 1 | $15 |
| Zyla Life Sciences, Inc. | 1 | $15 |
| Mallinckrodt Enterprises LLC | 1 | $12 |
| Medtronic | 1 | $12 |
| Abbott | 1 | $12 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
| Strongbridge US Inc. | 1 | $12 |
| Pfizer | 1 | $12 |
| Lilly USA, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,254 in reported general payments places this provider in the 65th percentile of 702 neurology providers in Ohio.
Other neurology in Uniontown
- Christopher SheppardUniontown$175K
- Aram ZabetiCincinnati$1.6M
- Kenneth MankowskiColumbus$1.4M
- Aaron BosterColumbus$1.2M
- Martin TaylorNew Albany$821K
- Jacqueline NicholasColumbus$743K
- Lawrence ElmerToledo$687K
- Kenneth PugarCenterville$582K
- Brendan BauerSheffield Village$548K
- Geoffrey EubankColumbus$508K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.